{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:37:56Z","timestamp":1792244276190,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,20]],"date-time":"2022-11-20T00:00:00Z","timestamp":1668902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jhepr.2022.100633","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T16:24:00Z","timestamp":1669393440000},"page":"100633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study"],"prefix":"10.1016","volume":"5","author":[{"given":"Frank","family":"Kolligs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Golfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7140-6775","authenticated-orcid":false,"given":"Maciej","family":"Pech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Peynircioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pfammatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7464-3939","authenticated-orcid":false,"given":"Maxime","family":"Ronot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4177-6417","authenticated-orcid":false,"given":"Bruno","family":"Sangro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklaus","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Maleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Munneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7620-2467","authenticated-orcid":false,"given":"Helena","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bleranda","family":"Zeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2377-2973","authenticated-orcid":false,"given":"Niels","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8814-8154","authenticated-orcid":false,"given":"Thomas","family":"Helmberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"D\u2019Archambeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugsan","family":"Balli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadik","family":"Bilgic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Fischbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Flamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Gr\u00f6zinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Robert","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Kuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Orsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"\u00d6zg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Ronot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Vit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2022.100633_bib1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, regional and national burden of primary liver cancer by subtype","volume":"161","author":"Rumgay","year":"2022","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.jhepr.2022.100633_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.jhepr.2022.100633_bib3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/hep.27443","article-title":"Prognosis of untreated hepatocellular carcinoma","volume":"61","author":"Giannini","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhepr.2022.100633_bib4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","article-title":"Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.jhepr.2022.100633_bib5","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2022.100633_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2022.100633_bib7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhepr.2022.100633_bib8","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/annonc\/mdy510","article-title":"Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Vogel","year":"2019","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.jhepr.2022.100633_bib9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.annonc.2021.02.014","article-title":"Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines","volume":"32","author":"Vogel","year":"2021","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.jhepr.2022.100633_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"issue":"20","key":"10.1016\/j.jhepr.2022.100633_bib11","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"10126","key":"10.1016\/j.jhepr.2022.100633_bib12","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jhepr.2022.100633_bib13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.jhepr.2022.100633_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.jhepr.2022.100633_bib15","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.23944","article-title":"Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival","volume":"52","author":"Hilgard","year":"2010","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jhepr.2022.100633_bib16","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.cgh.2013.04.028","article-title":"Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization","volume":"11","author":"Salem","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2022.100633_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jhepr.2022.100633_bib18","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.24451","article-title":"Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation","volume":"54","author":"Sangro","year":"2011","journal-title":"Hepatology"},{"issue":"19","key":"10.1016\/j.jhepr.2022.100633_bib19","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1200\/JCO.2017.76.0892","article-title":"SIRveNIB: selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinoma","volume":"36","author":"Chow","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.jhepr.2022.100633_bib20","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.jhepr.2022.100633_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.21037\/hbsn.2018.10.06","article-title":"The SIRveNIB and SARAH trials, radioembolization vs. sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future","volume":"7","author":"Sposito","year":"2018","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"8","key":"10.1016\/j.jhepr.2022.100633_bib22","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.2967\/jnumed.116.184713","article-title":"Resin versus glass microspheres for (90)Y transarterial radioembolization: comparing survival in unresectable hepatocellular carcinoma using pretreatment partition model dosimetry","volume":"58","author":"Van Der Gucht","year":"2017","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.jhepr.2022.100633_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4_suppl","key":"10.1016\/j.jhepr.2022.100633_bib24","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1200\/JCO.2020.38.4_suppl.516","article-title":"Major impact of personalized dosimetry using 90Y loaded glass microspheres SIRT in HCC: final overall survival analysis of a multicenter randomized phase II study (DOSISPHERE-01)","volume":"38","author":"Garin","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.jhepr.2022.100633_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00270-020-02642-y","article-title":"Clinical application of trans-arterial radioembolization in hepatic malignancies in Europe: first results from the prospective multicentre observational study CIRSE Registry for SIR-spheres therapy (CIRT)","volume":"44","author":"Helmberger","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"4","key":"10.1016\/j.jhepr.2022.100633_bib26","doi-asserted-by":"crossref","DOI":"10.2196\/16296","article-title":"Clinical application of radioembolization in hepatic malignancies: protocol for a prospective multicenter observational study","volume":"9","author":"Helmberger","year":"2020","journal-title":"JMIR Res Protoc"},{"issue":"6","key":"10.1016\/j.jhepr.2022.100633_bib27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.jhepr.2022.100633_bib28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system. The 2022 update","volume":"76","author":"Reig","year":"2021","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2022.100633_bib29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000517458","article-title":"A simple prognostic scoring system for hepatocellular carcinoma treated with selective internal radiation therapy","volume":"40","author":"Op den Winkel","year":"2022","journal-title":"Dig Dis"},{"issue":"7","key":"10.1016\/j.jhepr.2022.100633_bib30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/17474124.2020.1777856","article-title":"The efficacy, safety, and predictors of outcomes of transarterial radioembolization for hepatocellular carcinoma: a retrospective study","volume":"14","author":"Abdallah","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.jhepr.2022.100633_bib31","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2967\/jnumed.117.199752","article-title":"(90)Y radioembolization for locally advanced hepatocellular carcinoma with portal vein thrombosis: long-term outcomes in a 185-patient cohort","volume":"59","author":"Abouchaleh","year":"2018","journal-title":"J\u00a0Nucl Med"},{"issue":"7","key":"10.1016\/j.jhepr.2022.100633_bib32","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jvir.2018.03.018","article-title":"Radioembolization for hepatocellular carcinoma: a nationwide 10-year experience","volume":"29","author":"Tohme","year":"2018","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"3","key":"10.1016\/j.jhepr.2022.100633_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2967\/jnumed.114.145177","article-title":"Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis","volume":"56","author":"Garin","year":"2015","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.jhepr.2022.100633_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hep.21980","article-title":"Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis","volume":"47","author":"Kulik","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhepr.2022.100633_bib35","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2017.12.026","article-title":"Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion","volume":"68","author":"Spreafico","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2022.100633_bib36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/17474124.2020.1748010","article-title":"ALBI versus child-pugh in predicting outcome of patients with HCC: a systematic review","volume":"14","author":"Peng","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2022.100633_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jvir.2019.08.033","article-title":"Toxicity and survival of hepatocellular carcinoma patients with hepatitis B infection treated with yttrium-90 radioembolization: an updated 15-year study","volume":"31","author":"Gao","year":"2020","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"4","key":"10.1016\/j.jhepr.2022.100633_bib38","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/hep.29691","article-title":"Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience","volume":"68","author":"Salem","year":"2018","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jhepr.2022.100633_bib39","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00259-018-3968-5","article-title":"Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies","volume":"45","author":"Sangro","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.jhepr.2022.100633_bib40","doi-asserted-by":"crossref","DOI":"10.1148\/ryct.2021210007","article-title":"Anatomic variations of the hepatic artery in 5625 patients","volume":"3","author":"Choi","year":"2021","journal-title":"Radiol Cardiothorac Imaging"},{"issue":"15","key":"10.1016\/j.jhepr.2022.100633_bib41","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1016\/j.jbiomech.2016.09.034","article-title":"Numerical investigation of liver radioembolization via computational particle-hemodynamics: the role of the microcatheter distal direction and microsphere injection point and velocity","volume":"49","author":"Aramburu","year":"2016","journal-title":"J\u00a0Biomech"},{"issue":"2","key":"10.1016\/j.jhepr.2022.100633_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1055\/s-0039-1694091","article-title":"Vascular redistribution for SIRT\u2014a quantitative assessment of treatment success and long-term analysis of recurrence and survival outcomes","volume":"3","author":"Borg","year":"2019","journal-title":"J\u00a0Clin Interv Radiol ISVIR"},{"issue":"2","key":"10.1016\/j.jhepr.2022.100633_bib43","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1148\/rg.2019180095","article-title":"Expected and unexpected imaging findings after (90)Y transarterial radioembolization for liver tumors","volume":"39","author":"Spina","year":"2019","journal-title":"Radiographics"},{"issue":"6","key":"10.1016\/j.jhepr.2022.100633_bib44","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jhep.2021.07.037","article-title":"Liver function after combined selective internal radiation therapy or sorafenib monotherapy in advanced hepatocellular carcinoma","volume":"75","author":"Ricke","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2022.100633_bib45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00270-020-02643-x","article-title":"Short-term safety and quality of life outcomes following radioembolization in primary and secondary liver tumours: a multi-centre analysis of 200 patients in France","volume":"44","author":"Loffroy","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"10.1016\/j.jhepr.2022.100633_bib46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MEG.0000000000000772","article-title":"Radioembolization-induced liver disease: a systematic review","volume":"29","author":"Braat","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.jhepr.2022.100633_bib47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s12149-011-0499-6","article-title":"Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: a technical review","volume":"25","author":"Kao","year":"2011","journal-title":"Ann Nucl Med"},{"issue":"3","key":"10.1016\/j.jhepr.2022.100633_bib48","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.26191","article-title":"Prognostic factors and prevention of radioembolization-induced liver disease","volume":"57","author":"Gil-Alzugaray","year":"2013","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jhepr.2022.100633_bib49","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/cncr.23339","article-title":"Liver disease induced by radioembolization of liver tumors: description and possible risk factors","volume":"112","author":"Sangro","year":"2008","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jhepr.2022.100633_bib50","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1148\/radiol.2020191606","article-title":"Relationship of tumor radiation-absorbed dose to survival and response in hepatocellular carcinoma treated with transarterial radioembolization with (90)Y in the SARAH study","volume":"296","author":"Hermann","year":"2020","journal-title":"Radiology"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922002051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922002051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:31:16Z","timestamp":1762900276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555922002051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2589555922002051"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100633","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100633"}}